Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 4
Submit an article Journal homepage
117
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Association between proteomic profile and molecular response in chronic myeloid leukemia patients

Vito Michele GarrisiClinical and Experimental Pathology Laboratory, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy; Correspondence[email protected]
,
Nicola SgherzaHematology and Stem Cell Transplantation Unit, “Casa Sollievo della Sofferenza” Hospital, San Giovanni Rotondo, Italy;
,
Massimo BrecciaDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;
,
Angela IacobazziHematology Unit, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy
,
Giacoma De TullioHematology Unit, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy
,
Giovanni NardelliHematology Unit, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy
,
Antonio NegriHematology Unit, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy
,
Rosa DivellaClinical and Experimental Pathology Laboratory, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy;
,
Antonella DanieleClinical and Experimental Pathology Laboratory, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy;
,
Giuseppina MicelliClinical and Experimental Pathology Laboratory, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy;
,
Antonio TufaroClinical and Experimental Pathology Laboratory, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy;
,
Nicola CascavillaHematology and Stem Cell Transplantation Unit, “Casa Sollievo della Sofferenza” Hospital, San Giovanni Rotondo, Italy;
,
Eufemia SavinoClinical and Experimental Pathology Laboratory, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy;
,
Ines AbbateClinical and Experimental Pathology Laboratory, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy;
&
Attilio GuariniHematology Unit, National Cancer Research Centre Istituto Tumori “Giovanni Paolo II”, Bari, Italy
 show all
Pages 1016-1018 | Received 29 Sep 2016, Accepted 10 Jun 2017, Published online: 11 Jul 2017

References

  • Baccarani M, Deininger MW, Rosti G, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013;122:872–884.
  • Cortes J, Quintas-Cardama A, Kantarjian HM. Monitoring molecular response in chronic myeloid leukemia. Cancer. 2011;117:1113–1122.
  • Khorashad JS, Kelley TW, Szankasi P, et al. BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships. Blood. 2013;121(3):489–449.
  • Hudler P, Kocevar N, Komel R. Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics. Sci World J. 2014;2014:260348.
  • Zheng PZ, Wang KK, Zhang QH, et al. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. PNAS. 2005;102:7653–7658.
  • Garrisi VM, Strippoli S, De Summa S, et al. Proteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutation. PLoS One. 2014;9:e112025.
  • Paradis V, Degos F, Dargere D, et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology. 2005;41:40–47.
  • Zhang Z, Bast RC, Yu Y, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage of ovarian cancer. Cancer Res. 2004;64:5882–5890.
  • Kwak JY, Ma TZ, Yoo MJ, et al. The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia. Exp Hematol. 2004;32:836–842.
  • Orlandi R, De Bortoli M, Ciniselli CM, et al. Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer. Ann Oncol. 2014;25:352–357.
  • Mossuz P, Bouamrani A, Brugière S, et al. Apolipoprotein A1: a new serum marker correlated to JAK2 V617F proportion at diagnosis in patients with polycythemia vera. Proteom Clin Appl. 2007;1(12):1605–1612.
  • Alaiya A, Chaundhri NA, Malhan H, et al. Proteomics-based approach predicts molecular response and stratifies responders to tyrosine kinase inhibitors (TKI) in Chronic Myeloid Leukemia (CML) patients. Blood. 2014;124:4556.
  • Lee SH, Zhu C, Peng Y, et al. Identification of a novel role of ZMIZ2 protein in regulating the activity of the Wnt/β-catenin signaling pathway. J Biol Chem. 2013;288:35913–35924.
  • Ashihara E, Takada T, Maekawa T. Targeting the canonical Wnt/β-catenin pathway in hematological malignancies. Cancer Sci. 2015;106:665–671.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.